The combined word "QuickStrip" with speed stripes to the left of the letter "Q", the word "Quick" in bold and the word "Strip" underlined.
Mark For: QUICKSTRIP™ trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The combined word "QuickStrip" with speed stripes to the left of the letter "Q", the word "Quick" in bold and the word "Strip" underlined.
Research | OneLook Acronym Finder |
Serial Number | 88163086 |
Mark Literal Elements | QUICKSTRIP |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2020-09-30 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | Yes |
Attorney Name | Todd A. Van Thomme |
Attorney Docket Number | 3009575-2014 |
Law Office Assigned | L80 |
Employee Name | LOOK, JEFFREY J |
2018-10-21 | Application Filed |
2019-07-26 | Status: Live/Pending |
2019-11-07 | Location: GENERIC WEB UPDATE |
2019-11-20 | Transaction Date |
2020-09-30 | Location: PUBLICATION AND ISSUE SECTION |
2020-11-03 | Published |
2021-05-03 | Status: An opposition after publication is pending at the Trademark Trial and Appeal Board. For further information, see TTABVUE on the |
Party: | Rapid Dose Therapeutics Inc. |
Address | Unit 3 1121 Walkers Line Burlington, Ontario CANADA L7N2G4 |
Legal Entity Type | Corporation |
Legal Entity State | CANADA |
Drawing | IMAGE/JPEG | 2018-10-21 |
TEAS RF New Application | APPLICATION/XML,IMAGE/JPEG | 2018-10-21 |
Design Search Code Corr Project | APPLICATION/XML | 2018-11-02 |
Change of Address | XML | 2019-06-19 |
Offc Action Outgoing | MULTI | 2019-07-26 |
XSearch Search Summary | XML | 2019-07-26 |
TEAS Rev, App and/or COA of Atty/Dom.Rep | XML | 2019-09-05 |
Administrative Response | XML | 2019-11-07 |
Response to Office Action | APPLICATION/XML,IMAGE/TIFF | 2020-01-24 |
Amendment and Mail Process Complete | MULTI | 2020-02-06 |
Offc Action Outgoing | XML | 2020-03-18 |
Examiners Amendment | XML | 2020-09-29 |
Amendment and Mail Process Complete | MULTI | 2020-09-30 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-10-01 |
Notice of Publication | XML | 2020-10-14 |
Notification Of Notice of Publication | XML | 2020-10-14 |
OG Publication Confirmation | APPLICATION/XML | 2020-11-03 |
26.17.05 | Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal |
26.17.13 | Letters or words underlined and/or overlined by one or more strokes or lines; Overlined words or letters; Underlined words or letters |
261701 | Bands, straight; Bars, straight; Lines, straight; Straight line(s), band(s) or bar(s) |
261705 | Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal |
261713 | Letters or words underlined and/or overlined by one or more strokes or lines; Overlined words or letters; Underlined words or letters |
IC 044. US 100 101. G & S: Consulting in the field of orally dissolvable films containing nutraceuticals, namely, biotin, folic acid, resveratrol, DHEA, NAD, curcumin; consulting in the field of orally dissolvable films containing, vitamins, caffeine, melatonin, herbal supplements for general health and well-being, dietary supplements for general health and well being, nicotine and nicotine-polymer complexes; consulting in the field of orally dissolvable films containing non-prescription pharmaceutical preparations sold over-the-counter for the relief of pain, cough, cold, flu, allergy symptoms, cardiac health, nicotine smoking cessation, anti-gas for stomach bloating, anemia, and to promote wound healing; consulting in the field of orally dissolvable films containing prescription pharmaceutical preparations indicated for the relief of nausea, vomiting, hyperglycemia, diabetes, erectile dysfunction, anti-anxiety, anti-depressant, migraine headache pain, anemia, cardiac health, angina, hypertension, and to reverse and prevent opioid overdose; consulting in the field of orally dissolvable films containing human vaccine and human biologic medications which function as biologic response modifiers in the human immune system for the treatment and prevention of influenza, auto-immune disease syndrome (AIDS), HIV infections, inflammatory bowel disease, Crohn's Disease, Ulcerative Colitis, rheumatoid arthritis, diabetes, insulinemia, psoriasis, herpes, HPV prevention, polio, tuberculosis, hepatitis, diptheria, typhoid, meningitis, multiple schlerosis, lupus, Varicella viral infections (chicken pox), West Nile Virus infections, H1N1 flu infections, cancer, and age-related Macular Degeneration
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 7 |
U.S. Codes: | 013,019,021,023,031,034,035 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
CC0000 | Color is not claimed as a feature of the mark. |
Description | Date | Proceeding Number |
---|---|---|
OPPOSITION INSTITUTED NO. 999999 | 2021-05-03 | 269101 |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2020-11-18 | |
PUBLISHED FOR OPPOSITION | 2020-11-03 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-11-03 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-10-14 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-09-30 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-09-29 | 6328 |
EXAMINERS AMENDMENT E-MAILED | 2020-09-29 | 6328 |
EXAMINERS AMENDMENT -WRITTEN | 2020-09-29 | 72008 |
EXAMINER'S AMENDMENT ENTERED | 2020-09-29 | 88888 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-03-18 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-03-18 | 72008 |
NON-FINAL ACTION E-MAILED | 2020-03-18 | 6325 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-02-05 | 68123 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-02-05 | 68123 |
ASSIGNED TO LIE | 2020-01-30 | 68123 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-01-24 | |
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | 2019-11-20 | 72008 |
LETTER OF PROTEST EVIDENCE FORWARDED | 2019-11-07 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-09-05 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-09-05 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-07-26 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-07-26 | 72008 |
NON-FINAL ACTION E-MAILED | 2019-07-26 | 6325 |
ASSIGNED TO EXAMINER | 2019-07-19 | 72008 |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-06-19 | |
ASSIGNED TO EXAMINER | 2019-01-28 | 88577 |
ASSIGNED TO EXAMINER | 2019-01-25 | 94062 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2018-11-02 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-11-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.